A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve MDMA as a prescription medication for the treatment of post-traumatic stress disorder (PTSD). The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday that it submitted the new drug application (NDA) to FDA, requesting an […]| Marijuana Moment
A new study funded by the National Institute on Drug Abuse (NIDA) has found that a citrusy-smelling terpene in marijuana could help ease anxiety and paranoia associated with THC. The findings, researchers say, could help unlock the maximum therapeutic benefit of THC and protect public health. Published in the latest issue of the journal Drug […]| Marijuana Moment